Internal Medicine MedicalOncology MedicalOncology MedicalOncology Ambulatory SurgicalCenter Internal Medicine Internal Medicine Internal Medicine Ophthalmology Hematology/Oncology Hematology/Oncology Hematology/Oncology $466,969,222 $248,212,119 $162,519,904 $2,982,942,674 2019Total (in dollars) 1st Top Specialty 2nd Top Specialty 3rd Top 3rd Specialty 2nd Top Specialty 1stTopSpecialty (in dollars) afterexclusions Allowed Charges, injection Octreotideinjection, depot Romiplostiminjection Brentuximabvedotin inj J0178 J2353 J2796 J9042 oe Short Description* Codes List of HCPCS 97 n eboiua 2853726Hmtlg/nooyItra eiieMedicalOncology MedicalOncology Rheumatology Rheumatology Internal Medicine MedicalOncology Internal Medicine MedicalOncology Internal Medicine Internal Medicine Hematology/Oncology Ambulatory SurgicalCenter Internal Medicine $2,815,337,226 Internal Medicine Hematology/Oncology $1,878,981,569 Hematology/Oncology Hematology/Oncology $1,865,991,330 $1,721,580,561 Internal Medicine Ophthalmology Gastroenterology Internal Medicine $1,295,341,479 Hematology/Oncology Hematology/Oncology $1,099,476,084 Inj $1,242,697,080 Injection, Rheumatology J9271 Inj.,, 10mg $1,010,328,165 J9299 Denosumabinjection J9312 Ranibizumabinjection 1 Injection, J0897 2 6mg J2778 injection 3 J2505 Infliximabbiosimil not 4 10mg J9035 5 J1745 6 7 8 9 0J19Aaaetijcin$6,5,3 huaooyItra eiieHematology/Oncology Internal Medicine Internal Medicine MedicalOncology MedicalOncology MedicalOncology Internal Medicine MedicalOncology MedicalOncology NursePractitioner Hematology/Oncology MedicalOncology Hematology/Oncology Rheumatology Pulmonary Disease $968,556,135 NursePractitioner Internal Medicine Internal Medicine Internal Medicine Internal Medicine Hematology/Oncology Neurology $851,042,669 MedicalOncology Internal Medicine MedicalOncology Hematology/Oncology $562,413,430 Hematology/Oncology Internal Medicine Neurology Internal Medicine $539,680,121 Ophthalmology $843,712,153 Internal Hematology/Oncology Medicine $703,104,359 Hematology/Oncology Internal Medicine Hematology/Oncology $486,551,001 PhysicalMedicine and Rehabilitation Internal Medicine Abataceptinjection $476,638,073 MedicalOncology MedicalOncology Hematology/Oncology Inj exclbiosimi Internal Medicine MedicalOncology Hematology/Oncology J0129 Injection, $436,302,629 10 mg Internal Medicine Dermatology Rheumatology Allergy/Immunology J9355 Injection, , 1mg $458,757,878 $423,947,996 Hematology/Oncology J9145 injection 10 J2350 injection MedicalOncology Internal Medicine Internal Medicine MedicalOncology 11 Gastroenterology J1300 Inj, ,10mg Neurology Internal Medicine Rheumatology Internal Medicine 12 J9305 Inj., ,10 mg $362,050,123 $389,236,097 Hematology/Oncology $368,492,761 Hematology/Oncology Nephrology 13 J9022 $331,065,114 $333,264,824 14 J9173 Certolizumabpegol inj 1mg Hematology/Oncology Internal Medicine 15 Internal Medicine Inj., velcade 0.1 mg Internal Medicine 16 Urology J0717 injection Gastroenterology Pulmonary Disease Rheumatology Hematology/Oncology 17 MedicalOncology J9041 Injection,onabotulinumtoxina Hematology/Oncology $331,012,840 Hematology/Oncology $279,068,051 $318,023,592 18 MedicalOncology J2357 iv for use 1mg $278,600,806 Hematology/Oncology $296,821,394 19 J0585 Injection, Internalvedolizumab Medicine Internal Medicine 20 J1602 Paclitaxel protein bound Sports Medicine Hematology/Oncology Internal Medicine Neurology 21 J3380 injection MedicalOncology MedicalOncology Hematology/Oncology Rheumatology Internal Medicine Hematology/Oncology $255,449,074 22 J9264 Leuprolideacetate suspnsion $258,409,215 $264,386,412 $219,156,831 Pulmonary Disease 23 J9228 Injection, , 1 mg Hematology/Oncology 24 J9217 Injection, carfilzomib, 1 mg $187,518,352 25 J9306 Tocilizumabinjection Internal Medicine Urology 26 Internal Medicine J9047 Lanreotide injection $182,158,187 27 Internal Medicine Interventional Cardiology J3262 Ustekinumabsub inj, 1mg cu 28 J1930 Darbepoetinalfa, non-esrd Hematology/Oncology Allergy/Immunology PhysicianAssistant 29 J3357 injection Hematology/Oncology $162,477,948 $177,640,239 Internal Medicine 30 J0881 Internal Medicine Internal $173,008,338 Medicine 31 J2323 Inj., bendeka 1mg OrthopedicSurgery Internal Medicine 32 Epoetinalfa, non-esrd Hematology/Oncology Hematology/Oncology $152,408,630 33 Cardiology J9034 Sipuleucel-t auto cd54+ $155,483,502 $157,438,453 34 J0885 Injection, $150,339,213 , 1mg Rheumatology Allergy/Immunology 35 Inj ferriccarboxymaltos 1mg Q2043 $123,947,596 $136,977,827 36 J2182 37 J1439 injection 38 Inj, ado-trastuzumab 1mg emt 39 J9055 Injection, udenyca 0.5 mg 40 J9354 Orthovisc inj per dose 41 Regadenosoninjection Q5111 42 J7324 Inj., , 1 mg 43 J2785 Pegloticase injection 44 J0517 45 J2507 46 47 48 Rank TABLE 2: PERFORMANCE YEAR 1 MFN MODEL DRUG HCPCS CODES LIST WITH TOP BILLING SPECIALTIES BILLING WITH TOP LIST DRUGCODES 1 MFN HCPCS MODEL YEAR 2: PERFORMANCE TABLE 2019Total (in dollars) 1st Top Specialty 2nd Top Specialty 3rd Top 3rd Specialty 2nd Top Specialty 1stTopSpecialty (in dollars) afterexclusions Allowed Charges, oe Short Description* Codes List of HCPCS 9J16Ijcin ltzmb m 137569Hmtlg/nooyItra eiieMedicalOncology MedicalOncology Internal Medicine Internal Medicine Hematology/Oncology $123,725,659 Hematology/Oncology $121,583,613 Injection, , 1mg Inj rituximab, hyaluronidase J9176 J9311 49 50 Table 3 shows the distribution of total 2019 Medicare Part B allowed charges for the drugs identified in Table 2 by provider 2 by provider Table in the drugs identified charges for B Part allowed 2019 Medicare of 3 shows the distribution total Table Note: Ambulatory Surgical isincludedCenter as specialty a showto drugutilization this in setting. *Theshortdescription effective ofas January 1, 2021. Rank and supplier type to show the types of providers and suppliers that had claims for these separately payable Medicare Part B drugs in B Part drugs Medicare payable separately for claims these had and that showof the types suppliers type to providers and supplier of bill, provider type processed the claim, type ofthat MAC we the considered or a type, supplier to provider claims 2019. To assign the drugline. claim with associated care practitioner of specialty the health and of code, service place line center, number, revenue